ITL Health Group (ASX:ITD) was featured on Biotech Daily, a website which provides daily news on ASX-listed biotechnology companies.
Friday, 29th June 2018
Dr Boreham’s Crucible: ITL Health
Read article → Biotech Daily ITL Health Group Jun 29 2018
Essentials for Blood Management and Clinical Procedures
ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.
ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.
Read More
